vanderbilt-Ingram Cancer Center — Nashville, Tennessee

vanderbilt-Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

vanderbilt-Ingram Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Melanoma, Solid Tumor, Pilocytic Astrocytoma.

Sponsors: Day One Biopharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for vanderbilt-Ingram Cancer Center?

vanderbilt-Ingram Cancer Center has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has vanderbilt-Ingram Cancer Center conducted?

vanderbilt-Ingram Cancer Center has 1 clinical trials on record. Their work covers Melanoma, Solid Tumor, Pilocytic Astrocytoma.

Is vanderbilt-Ingram Cancer Center accredited by Crixeo Health?

vanderbilt-Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about vanderbilt-Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.